loxiglumide has been researched along with Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kashima, K; Kataoka, K; Kato, M; Kuriyama, K; Mukainaka, T; Ohkuma, S | 1 |
| Bamba, T; Hosoda, S; Ishizuka, Y | 1 |
2 other study(ies) available for loxiglumide and Hypertrophy
| Article | Year |
|---|---|
Mechanisms for pancreatic hypertrophy induced by long-term administration of bethanechol.
Topics: Amylases; Animals; Atropine; Bethanechol; Cholinergic Agonists; Cholinergic Antagonists; Drug Administration Schedule; Drug Interactions; Gastrins; Hypertrophy; Male; Organ Size; Pancreas; Pentagastrin; Proglumide; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide | 1994 |
Effect of intrinsic CCK and CCK antagonist on pancreatic growth and pancreatic enzyme secretion in pancreaticobiliary diversion rats.
Topics: Amylases; Animals; Biliary Tract Surgical Procedures; Cholecystokinin; Hypertrophy; Lipase; Male; Pancreas; Proglumide; Rats; Rats, Wistar; Secretin; Time Factors; Trypsinogen | 1993 |